Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - AVANIR PHARMACEUTICALS, INC. | d259667d10k.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - AVANIR PHARMACEUTICALS, INC. | d259667dex311.htm |
| EX-10.24 - FORM OF CHANGE OF CONTROL AGREEMENT - AVANIR PHARMACEUTICALS, INC. | d259667dex1024.htm |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - AVANIR PHARMACEUTICALS, INC. | d259667dex312.htm |
| EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - AVANIR PHARMACEUTICALS, INC. | d259667dex321.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - AVANIR PHARMACEUTICALS, INC. | d259667dex231.htm |
| EXCEL - IDEA: XBRL DOCUMENT - AVANIR PHARMACEUTICALS, INC. | Financial_Report.xls |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO SECTION 906 OF
THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. SECTION 1350)
In connection with the accompanying Annual Report of AVANIR Pharmaceuticals (the “Company”) on Form 10-K for the fiscal year ended September 30, 2011 (the “Report”), I, Christine G. Ocampo, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: December 13, 2011 | /s/ Christine G. Ocampo | |
| Christine G. Ocampo | ||
| Vice President, Finance | ||
| [Principal Financial Officer] |